The Universal Medica’s “Chinese Pharma&Biotech Press Review” (CPBPR) gives you key information to succeed for business in China.

The CPBPR is published weekly with essential information from the latest pharmaceutics, biotechnologies and healthcare news from China.

Accurate, concise and practical, the CPBPR is a weekly e-newsletter that selects, organizes and summarizes the main activities of the pharmaceutical and biotechnological market in China.

The CPBPR is structured around several major topics: pharmaceuticals information, biotechnology, scientific research, events. It provides relevant overall visibility to be informed of the main trends and latest market opportunities, diseases, health products and information on the industry conventions and conferences in China and Asia.

Written by a team of scientific and marketing experts based in Shanghai, "China Pharma&Biotech Press Review" is a strategic tool that delivers quality information and not-to-be-missed opportunities to predict the market growth of China and Asia.

With its variety of reference sources, the CPBPR is a strategic and reliable competitive intelligence tool that reduces the gap between the Chinese market and foreign companies.

Download an example of CPBPR

For more information, please fill in this form  

2011 book of chinese pharma and healthcare press review

2011 press review on Chinese pharma, biotech, R&D, events and healthcare news synthesized in a book.

Main features:
•    More than 400 selected articles on healthcare
•    More than 200 selected articles on pharmaceuticals
•    More than 60 selected articles on biotechnology
•    20 major scientific events occurred in China
•    A top selection of articles: major events of the Chinese market that occurred in 2011
•    Selected figures and charts to complete 2011 major information
•    Market outlook
And more features…

Interested? To get more information or to order it, contact us.

Special 50% discount for any order before the 19th February 2012:  690€  instead of 1390€